Removal of transmucosal buprenorphine PA requirements for Kentucky Medicaid enrollees was associated with a significant immediate increase in buprenorphine dispensing for OUD treatment.
Buprenorphine utilization following removal of prior authorization requirements in the Kentucky Medicaid population